VITROS CHEMISTRY PRODUCTS VALP REAGENT 6801710

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-11-07 for VITROS CHEMISTRY PRODUCTS VALP REAGENT 6801710 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[128434455] The investigation determined that lower than expected valproic acid (valp) results were obtained from patient samples processed as part of a valp lot to lot correlation using a vitros 4600 chemistry system. The most likely assignable causes for this event are valp lot to lot variability and calibration to calibration variability. There was no indication of a performance issue with the vitros valp lots (2511-25-6067, 2511-26-6711 and 2511-26-6892) used in the patient correlation based on quality control (qc) performance; however, the vitros valp lot 2511-25-6067 accuracy was lower than both valp lots 2511-26-6711 and 2511-26-6892 as shown with the patient correlation results. Valp gen 26 performance was set to the reference method at release and resulted in a shift high over gen 25 performance. It was confirmed by ortho that both vitros valp gen 25 and gen 26 lots have performed within ortho release guidelines. The performance of vitros controls were acceptable and ortho release data was within specifications. Furthermore, the customer indicated that any shift in patient data seen was not considered to be clinically significant at the time. Additionally, because pre-analytical specimen storage and handling information were not provided, pre-analytical sample handling and storage cannot be ruled out as a contributing factor to this event.
Patient Sequence No: 1, Text Type: N, H10


[128434456] A customer obtained lower than expected valproic acid (valp) results from patient samples using a vitros 4600 chemistry system in combination with vitros valp reagent. Sample 1 = 35. 7 versus expected 52. 3 mg/l. Sample 2 = 23. 4 versus expected 34. 5 mg/l. Sample 3 = 79. 5 versus expected 104. 8 mg/l. Sample 4 = 91 versus expected 118 mg/l. Sample 6 = 102. 8 versus expected 128. 7 mg/l. Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected. Ortho has not been made aware of any erroneous patient sample results that were obtained or reported from the laboratory. There was no allegation of patient harm as a result of this event. This report corresponds to ortho clinical diagnostics inc. Complaint numbers (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1319808-2018-00045
MDR Report Key8048155
Date Received2018-11-07
Date of Report2019-01-04
Date of Event2018-10-04
Date Mfgr Received2018-10-11
Device Manufacturer Date2017-05-05
Date Added to Maude2018-11-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO-CLINICAL DIAGNOSTICS
Manufacturer Street1000 LEE ROAD
Manufacturer CityROCHESTER NY 14606
Manufacturer CountryUS
Manufacturer Postal Code14606
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS CHEMISTRY PRODUCTS VALP REAGENT
Generic NameIN VITRO DIAGNOSTICS
Product CodeLEG
Date Received2018-11-07
Catalog Number6801710
Lot Number2511-25-6067
Device Expiration Date2018-11-05
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2018-11-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.